We continue our showcase this week with our Head of Production, Roz!


Rosalyn “Roz” Quinton is a native Jersey girl, but has spent the last decade and a half living in Connecticut. Roz studied mass communications and marketing at Quinnipiac, and worked as a producer at a stop-motion studio as well as at a couple of local news stations before ending up at XVIVO. She’s been with us for over eight years now!

Roz lives with her husband of six years and their two adorable pets: Tank, the 4-year-old ketchup-packet-eating French bulldog, and Tophie, a 13-year-old cat.

Roz’s parallel parking skills are unparalleled, as are her scrapbooking abilities. She is an avid pinner on pinterest, a Zumba enthusiast, and enjoys baking and being crafty. Her favorite Girl Scout cookie is the Samoa.


XVIVO XPOSED continues today with one of our animators, Tony Bexley!


Born and raised in Cape Cod, Tony went on to study computer graphics and design at RIT and Springfield College. Afterward, he went to the Vancouver Film School to hone his skills in 3D, returning to XVIVO after his studies to take his rightful place as 3D point pusher.

Tony is soon-to-be-wed, living happily with his fiancée and their cat named Cat (bet you didn’t see that coming!). Tony enjoys gratuitous TV and movie watching, reading, and computer gaming. He prefers Star Wars over Star Trek, and is often kept up at night in fear that the new Star Wars movie will be terrible.

Tony loves his pub food — a delicious burger or a generous platter of fish and chips is the perfect way to start or end his day! He adamantly prefers the original Starcraft over its successor, and likes reading dystopian novels.

XVIVO, TEDMED, and Jeffrey Karp


We always excited to get to help the amazing speakers at the annual TEDMED conferences. This year, we are working with Dr. Jeffrey Karp of Harvard to illustrate his inspiring work on biomimicry.

Biomimicry is the term given to invention inspired by nature. Like us, our non-human cohabitants have gone through millennia of evolution, selection, and adaptation. Whether it be a shrub, a butterfly, or a cockroach, by understanding how these miraculous lifeforms do what they do, we’re already halfway toward making something for which nature has given proof-of-concept.

Jeff Karp is set to deliver his talk during TEDMED 2014, which runs from September 10-12. Don’t miss the chance to hear about the amazing things he’s doing across science and medicine.


Putting faces to talent. Introducing XVIVO XPOSED, where we’ll showcase one person from our team every couple of days! Today, we’ll start out with Barry Furlano, who, as of two months ago, has been with us for a full year!


Barry hails from Western Massachusetts, but chose to leave the picturesque Berkshires for the concrete jungle of NYC, where he’s been for the past thirteen years. There he joined NY’s vibrant music scene and played in a couple of bands while working as a Flame artist. Barry eventually took his VFX skills to freelance and himself to Connecticut, where he’s now a part of the XVIVO family as Lead Editor.

In college, Barry studied music theory and composition. When he’s not shredding on his guitar or entrenched in Premiere edits, you might find him nerding out with a science documentary or sharpening both his skills and knives in the art of furniture making. According to Barry, nothing beats a good pizza with a side of fries.

Barry lives with his wife of two years and their two lovable cats. Barry has been to over 70 Phish concerts and is proud of it!

Treatment of Spinal Muscular Atrophy

Drug Discovery & Development has included our video in their coverage of a recent Science paper about a new treatment for those with Spinal Muscular Atrophy.

Read the piece here.

Spinal Muscular Atrophy (SMA) is a debilitating disorder caused by a reduced amount of a protein called SMN. A mutation in the SMN2 gene results in improper splicing of its associated mRNA, leading to deficiency in overall SMN levels. Those affected by SMA suffer from severe motor impairment.

In a pre-clinical study recently published by Science, this new treatment has been shown to effectively increase life span and prevent SMA-related motor dysfunction in mice.